pyrithioxin has been researched along with Hypersensitivity, Type III in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brühl, W; Chrzczonowski, Z; Dyznarowska, H; Loth, E; Swierczyńska, Z; Szymańska-Cygler, B; Zabek, J | 1 |
1 other study(ies) available for pyrithioxin and Hypersensitivity, Type III
| Article | Year |
|---|---|
[Clinical and immunological effects of treatment of rheumatoid arthritis with pyrithioxin (Enerbol Polfa)].
Topics: Adult; Aged; Antigen-Antibody Complex; Arthritis, Rheumatoid; Chemical Phenomena; Chemistry; Drug Eruptions; Female; Follow-Up Studies; Humans; Immune Complex Diseases; Male; Middle Aged; Pyridines; Pyrithioxin | 1980 |